Castle Biosciences, Inc. Banner Image

Castle Biosciences, Inc.

  • Ticker CSTL
    Exchange NASDAQ More
  • Industry Diagnostic Substances More
  • Sector Healthcare More
Castle Biosciences, Inc. Logo Image
  • 201-500 Employees
  • Based in Friendswood, Texas
Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx®-Melanoma, DecisionDx®-CMSeq; www.SkinMelanoma.com), cutaneous squamousMore cell carcinoma (DecisionDx®-SCC, www.mySCCskincancer.com) and uveal melanoma (DecisionDx®-UM, DecisionDx®-PRAME and DecisionDx®-UMSeq; www.MyUvealMelanoma.com). Castle also has products in development for other underserved cancers, the most advanced of which is focused on patients who have a difficult-to-diagnose pigmented lesion. Castle Biosciences is based in Friendswood, Texas (Houston), and has laboratory operations in Phoenix, Arizona.
Castle Biosciences, Inc.

Most Recent Annual Report

Castle Biosciences, Inc.
MOST RECENT 2021 Annual Report and Form 10K

Older/Archived Annual Reports